fusidic acid has been researched along with sulbactam in 6 studies
Studies (fusidic acid) | Trials (fusidic acid) | Recent Studies (post-2010) (fusidic acid) | Studies (sulbactam) | Trials (sulbactam) | Recent Studies (post-2010) (sulbactam) |
---|---|---|---|---|---|
1,742 | 117 | 344 | 1,844 | 297 | 488 |
Protein | Taxonomy | fusidic acid (IC50) | sulbactam (IC50) |
---|---|---|---|
Beta-lactamase | Escherichia coli | 6.2 | |
Beta-lactamase | Shouchella clausii | 0.075 | |
Beta-lactamase | Pseudomonas aeruginosa | 0.37 | |
Beta-lactamase | Pseudomonas aeruginosa | 3 | |
Beta-lactamase | Aeromonas allosaccharophila | 4 | |
Beta-lactamase | Staphylococcus aureus | 6.5 | |
Beta-lactamase | Enterobacter cloacae | 1.4 | |
Beta-lactamase TEM | Escherichia coli | 4.3 | |
Beta-lactamase | Acinetobacter pittii | 1.12 | |
Beta-lactamase | Acinetobacter pittii | 7.758 | |
Beta-lactamase | Pseudomonas aeruginosa | 3 | |
Beta-lactamase | Escherichia coli | 2.4 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Dudzevicius, V; Sakalauskas, R; Vitkauskiene, A | 1 |
Apisarnthanarak, A; Mundy, LM | 1 |
Abouelfetouh, A; El-Nakeeb, M; Kassem, M; Naguib, M | 1 |
Cong, Y; Fan, B; Guan, J; Wang, X | 1 |
6 other study(ies) available for fusidic acid and sulbactam
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
[The impact of antibiotic use on hospital-acquired pneumonia: data of etiology tests].
Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Bronchoalveolar Lavage Fluid; Ceftazidime; Cefuroxime; Ciprofloxacin; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fusidic Acid; Gentamicins; Haemophilus Infections; Haemophilus influenzae; Humans; Male; Methicillin; Microbial Sensitivity Tests; Middle Aged; Penicillins; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Staphylococcus aureus; Sulbactam; Vancomycin Resistance | 2003 |
Successful treatment of disseminated methicillin-resistant Staphylococcus aureus with fosfomycin, cefoperazone/sulbactam and rifampin followed by fusidic acid and rifampin.
Topics: Anti-Bacterial Agents; Cefoperazone; Drug Therapy, Combination; Fosfomycin; Fusidic Acid; Humans; Male; Methicillin Resistance; Middle Aged; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Sulbactam | 2007 |
Investigation and Treatment of Fusidic Acid Resistance Among Methicillin-Resistant Staphylococcal Isolates from Egypt.
Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; Conjugation, Genetic; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Synergism; Egypt; Fusidic Acid; Gene Expression Regulation, Bacterial; Gentamicins; Humans; Methicillin; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Plasmids; Rifampin; Staphylococcal Infections; Sulbactam | 2017 |
Activity of Colistin in Combination with Meropenem, Tigecycline, Fosfomycin, Fusidic Acid, Rifampin or Sulbactam against Extensively Drug-Resistant Acinetobacter baumannii in a Murine Thigh-Infection Model.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Colistin; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Fosfomycin; Fusidic Acid; Meropenem; Mice; Microbial Sensitivity Tests; Minocycline; Rifampin; Sulbactam; Thienamycins; Tigecycline | 2016 |